Former BioMarin Pharmaceutical Inc. and AngioChem Executive Joins the biOasis Scientific Advisory Board

VANCOUVER, British Columbia, May 27, 2010 (GLOBE NEWSWIRE) -- biOasis Technologies Inc. (TSX-V:BTI) (http://www.bioasis.ca/) is pleased to announce the appointment of Dr. Reinhard Gabathuler to the Scientific Advisor Board (“SAB”) of the company. Dr. Gabathuler joins eminent SAB members: Dr. Michael Shannon, Dr. Avi Livnat, Dr. Lee Anderson, and Professor Terry Pearson to the SAB chaired by Professor Wilfred Jefferies.

MORE ON THIS TOPIC